BP
Ballentine Partners’s SPDR S&P Biotech ETF XBI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.47M | Hold |
17,771
| – | – | 0.02% | 249 |
|
|
2025
Q1 | $1.44M | Buy |
+17,771
| New | +$1.44M | 0.03% | 233 |
|
|
2024
Q2 | – | Sell |
-27,066
| Closed | -$2.57M | – | 809 |
|
|
2024
Q1 | $2.57M | Hold |
27,066
| – | – | 0.05% | 128 |
|
|
2023
Q4 | $2.42M | Hold |
27,066
| – | – | 0.05% | 126 |
|
|
2023
Q3 | $1.98M | Sell |
27,066
-283
| -1% | -$20.7K | 0.05% | 125 |
|
|
2023
Q2 | $2.28M | Sell |
27,349
-23,231
| -46% | -$1.93M | 0.05% | 112 |
|
|
2023
Q1 | $3.85M | Buy |
50,580
+9,700
| +24% | +$739K | 0.1% | 82 |
|
|
2022
Q4 | $3.39M | Buy |
40,880
+1,097
| +3% | +$91.1K | 0.1% | 76 |
|
|
2022
Q3 | $3.16M | Hold |
39,783
| – | – | 0.11% | 70 |
|
|
2022
Q2 | $2.96M | Buy |
+39,783
| New | +$2.96M | 0.1% | 73 |
|
|
2017
Q4 | – | Sell |
-1,496
| Closed | -$130K | – | 415 |
|
|
2017
Q3 | $130K | Hold |
1,496
| – | – | 0.01% | 368 |
|
|
2017
Q2 | $121K | Buy |
+1,496
| New | +$121K | 0.01% | 372 |
|